Robertson Stephens Wealth Management, LLC Relmada Therapeutics, Inc. Transaction History
Robertson Stephens Wealth Management, LLC
- $2.75 Billion
- Q4 2024
A detailed history of Robertson Stephens Wealth Management, LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Robertson Stephens Wealth Management, LLC holds 25,000 shares of RLMD stock, worth $6,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,000Holding current value
$6,500% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RLMD
# of Institutions
54Shares Held
8.29MCall Options Held
364KPut Options Held
46.5K-
Franklin Resources Inc San Mateo, CA1.3MShares$338,5590.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.26MShares$326,7430.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.23MShares$319,2610.0% of portfolio
-
Black Rock Inc. New York, NY573KShares$149,0610.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA495KShares$128,7370.04% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $7.44M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...